John M. Klopp
Director Técnico/Científico/I+D en ACER THERAPEUTICS INC. .
Perfil
John M.
Klopp is currently the Chief Technical Officer at Acer Therapeutics, Inc. Prior to this, he worked as the Senior Director-Manufacturing Management at Ultragenyx Pharmaceutical, Inc. from 2013 to 2018.
Mr. Klopp received his undergraduate degree from The Pennsylvania State University and his graduate degree from the University of California, Berkeley.
Cargos activos de John M. Klopp
| Empresas | Cargo | Inicio |
|---|---|---|
| ACER THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/09/2019 |
Antiguos cargos conocidos de John M. Klopp.
| Empresas | Cargo | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2018 |
Formación de John M. Klopp.
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Bolsa de valores
- Insiders
- John M. Klopp
